Rani Therapeutics Holdings Inc Cl A (RANI)

$1.10 +0.03 (2.80%)
Market Cap 132.35M
Revenue (ttm) 1.63M
Net Income (ttm) -29.67M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,820.25%
Debt to Equity Ratio 0.00
Volume 1,110,700
Avg Vol 1,105,610
Day's Range N/A - N/A
Shares Out 123.69M
Stochastic %K 93%
Beta 0.74
Analysts Strong Sell
Price Target $7.40

Company Profile

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes...

Industry: Biotechnology
Sector: Healthcare
Phone: 408 457 3700
Address:
2051 Ringwood Avenue, San Jose, United States
BBTAAPL
BBTAAPL May. 13 at 12:28 PM
$RANI what time earnings?
0 · Reply
wavw
wavw May. 13 at 2:15 AM
$RANI the ask at 1.12 is 84800. Why so high. Somebody betting either to short or parabolic move….last time similar move happened before it fell. Hope it goes up….
2 · Reply
BBTAAPL
BBTAAPL May. 12 at 11:44 PM
$WOK $RANI is another runner
0 · Reply
Fishbonee
Fishbonee May. 12 at 8:37 PM
$RANI
0 · Reply
BBTAAPL
BBTAAPL May. 12 at 12:57 PM
$RANI let’s roll this week! Back to the promise land
0 · Reply
randres
randres May. 12 at 12:40 PM
$RANI i think this week is the week🚀
0 · Reply
BBTAAPL
BBTAAPL May. 12 at 12:29 PM
$RANI what are the predictions for what happens next?
0 · Reply
wavw
wavw May. 12 at 12:26 PM
$RANI As of April 30, 2026, Rani Therapeutics (RANI) has a short interest of approximately 8.95 million shares, During this time period the stock fell below 1. Short sellers cover at very low price to maximize profits.
1 · Reply
Fishbonee
Fishbonee May. 11 at 8:31 PM
$RANI 📈 LFG
0 · Reply
BBTAAPL
BBTAAPL May. 11 at 7:48 PM
$RANI someone was buying today & knows something. About to get an AI pump
1 · Reply
Latest News on RANI
Rani Therapeutics to Participate in the H.C. Wainwright Annual BioConnect Investor Conference

May 12, 2026, 4:05 PM EDT - 19 hours ago

Rani Therapeutics to Participate in the H.C. Wainwright Annual BioConnect Investor Conference

Rani Therapeutics Appoints Dr. Sara Kenkare-Mitra as Strategic Advisor to Advance Platform and Clinical Strategy

Apr 9, 2026, 7:00 AM EDT - 4 weeks ago

Rani Therapeutics Appoints Dr. Sara Kenkare-Mitra as Strategic Advisor to Advance Platform and Clinical Strategy

Rani Therapeutics price target lowered to $5 from $9 at Canaccord

2026-04-01T11:31:50.000Z - 6 weeks ago

Rani Therapeutics price target lowered to $5 from $9 at Canaccord

Rani Therapeutics Holdings Earnings Call Transcript: Q4 2025

Mar 26, 2026, 4:30 PM EDT - 6 weeks ago

Rani Therapeutics Holdings Earnings Call Transcript: Q4 2025

Rani Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Corporate Update

Mar 26, 2026, 4:05 PM EDT - 6 weeks ago

Rani Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Corporate Update

Rani Therapeutics Holdings options imply 17.3% move in share price post-earnings

2026-03-26T18:20:16.000Z - 6 weeks ago

Rani Therapeutics Holdings options imply 17.3% move in share price post-earnings

Rani Therapeutics Appoints Jesper Høiland as Head of Strategy to Advance Corporate and Pipeline Prioritization

Mar 25, 2026, 4:53 PM EDT - 6 weeks ago

Rani Therapeutics Appoints Jesper Høiland as Head of Strategy to Advance Corporate and Pipeline Prioritization

Rani Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results

Mar 19, 2026, 4:05 PM EDT - 7 weeks ago

Rani Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results

Rani Therapeutics promotes Javadi to Chief Technical Officer

2026-01-28T12:15:42.000Z - 3 months ago

Rani Therapeutics promotes Javadi to Chief Technical Officer

Rani Therapeutics Announces the Promotion of Alireza Javadi, Ph.D. to Chief Technical Officer

Jan 28, 2026, 7:00 AM EST - 3 months ago

Rani Therapeutics Announces the Promotion of Alireza Javadi, Ph.D. to Chief Technical Officer

Rani Therapeutics initiates Phase 1 study of RT-114 RaniPill

2026-01-08T12:10:14.000Z - 4 months ago

Rani Therapeutics initiates Phase 1 study of RT-114 RaniPill

Rani Therapeutics Initiates Phase 1 Study of RT-114 RaniPill® for the Treatment of Obesity in Collaboration with ProGen

Jan 8, 2026, 7:00 AM EST - 4 months ago

Rani Therapeutics Initiates Phase 1 Study of RT-114 RaniPill® for the Treatment of Obesity in Collaboration with ProGen

Largest borrow rate increases among liquid names

2025-12-22T13:45:20.000Z - 5 months ago

Largest borrow rate increases among liquid names

ABTC ASTL BILI CGC FCEL FRMI PSNY

Rani Therapeutics to Participate in the Evercore Healthcare Conference

Nov 24, 2025, 4:05 PM EST - 6 months ago

Rani Therapeutics to Participate in the Evercore Healthcare Conference

Rani Therapeutics files to sell 42.63M shares of Class A common stock for holder

2025-11-07T22:15:16.000Z - 6 months ago

Rani Therapeutics files to sell 42.63M shares of Class A common stock for holder

Rani Therapeutics Reports Third Quarter 2025 Financial Results; Provides Corporate Update

Nov 6, 2025, 4:30 PM EST - 6 months ago

Rani Therapeutics Reports Third Quarter 2025 Financial Results; Provides Corporate Update

Largest borrow rate increases among liquid names

2025-11-03T13:45:09.000Z - 6 months ago

Largest borrow rate increases among liquid names

ABR ASST KDK MSTX OMEX RVPH SMCX

Rani Therapeutics to Present Preclinical Data on Oral Delivery of Semaglutide via the RaniPill® Capsule at ObesityWeek® 2025

Oct 30, 2025, 8:00 AM EDT - 6 months ago

Rani Therapeutics to Present Preclinical Data on Oral Delivery of Semaglutide via the RaniPill® Capsule at ObesityWeek® 2025

Rani Therapeutics Announces the Appointments of Abe Bassan and Vasudev Bailey, Ph.D. to Board of Directors

Oct 23, 2025, 4:05 PM EDT - 7 months ago

Rani Therapeutics Announces the Appointments of Abe Bassan and Vasudev Bailey, Ph.D. to Board of Directors

Rani Therapeutics Announces Closing of Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules

Oct 23, 2025, 4:01 PM EDT - 7 months ago

Rani Therapeutics Announces Closing of Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules

Unusually active option classes on open October 21st

2025-10-21T13:40:24.000Z - 7 months ago

Unusually active option classes on open October 21st

BILI BYND CLOV KO MMM NEM PM

Rani Therapeutics assumed with a Buy at H.C. Wainwright

2025-10-21T10:20:12.000Z - 7 months ago

Rani Therapeutics assumed with a Buy at H.C. Wainwright

Rani Therapeutics price target raised to $10 from $5 at Maxim

2025-10-20T15:55:16.000Z - 7 months ago

Rani Therapeutics price target raised to $10 from $5 at Maxim

CRMD, RANI, CELC, RAPT: four biotech stocks flying high today and why

Oct 20, 2025, 9:42 AM EDT - 7 months ago

CRMD, RANI, CELC, RAPT: four biotech stocks flying high today and why

CELC CRMD RAPT

Why This Penny Biotech Stock Is Still Climbing After a 250% Surge

2025-10-20T12:34:38.000Z - 7 months ago

Why This Penny Biotech Stock Is Still Climbing After a 250% Surge

Rani Therapeutics signs up to $1.09 billion licensing deal with Japan's Chugai Pharma

Oct 17, 2025, 7:48 AM EDT - 7 months ago

Rani Therapeutics signs up to $1.09 billion licensing deal with Japan's Chugai Pharma

Rani Therapeutics Announces Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules

Oct 17, 2025, 7:31 AM EDT - 7 months ago

Rani Therapeutics Announces Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules

Rani Therapeutics Announces up to $1.085 Billion Collaboration with Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including Rare Disease and Immunology Programs and Announces Concurrent Oversubscribed $60.3 Million Financing

Oct 17, 2025, 7:30 AM EDT - 7 months ago

Rani Therapeutics Announces up to $1.085 Billion Collaboration with Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including Rare Disease and Immunology Programs and Announces Concurrent Oversubscribed $60.3 Million Financing

Rani Therapeutics Reports Second Quarter 2025 Financial Results; Provides Corporate Update

Aug 7, 2025, 4:05 PM EDT - 9 months ago

Rani Therapeutics Reports Second Quarter 2025 Financial Results; Provides Corporate Update

Rani Therapeutics Holdings, Inc. Announces Pricing of $3.0 Million Registered Direct Offering

Jul 15, 2025, 9:00 AM EDT - 10 months ago

Rani Therapeutics Holdings, Inc. Announces Pricing of $3.0 Million Registered Direct Offering

Rani Therapeutics and ProGen Announce Late Breaking Presentation at ENDO 2025 Demonstrating Bioequivalence of Novel, Bispecific GLP-1/GLP-2 Receptor Agonist Delivered Orally via RaniPill Compared to Subcutaneous Delivery

Jul 14, 2025, 5:00 AM EDT - 10 months ago

Rani Therapeutics and ProGen Announce Late Breaking Presentation at ENDO 2025 Demonstrating Bioequivalence of Novel, Bispecific GLP-1/GLP-2 Receptor Agonist Delivered Orally via RaniPill Compared to Subcutaneous Delivery

Rani Therapeutics Announces Research Agreement with Chugai

May 19, 2025, 8:00 AM EDT - 1 year ago

Rani Therapeutics Announces Research Agreement with Chugai

Rani Therapeutics Reports First Quarter 2025 Financial Results; Provides Corporate Update

May 13, 2025, 4:05 PM EDT - 1 year ago

Rani Therapeutics Reports First Quarter 2025 Financial Results; Provides Corporate Update

Rani Therapeutics Holdings Earnings Call Transcript: Q4 2024

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Rani Therapeutics Holdings Earnings Call Transcript: Q4 2024

Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update

Mar 31, 2025, 4:05 PM EDT - 1 year ago

Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update

Rani Therapeutics Announces Preclinical Data Demonstrating Bioequivalence of RT-114, a GLP-1/GLP-2 Dual Agonist (PG-102) Delivered Orally via the RaniPill® Capsule, to Subcutaneously Administered PG-102

Mar 26, 2025, 4:05 PM EDT - 1 year ago

Rani Therapeutics Announces Preclinical Data Demonstrating Bioequivalence of RT-114, a GLP-1/GLP-2 Dual Agonist (PG-102) Delivered Orally via the RaniPill® Capsule, to Subcutaneously Administered PG-102

Rani Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results

Mar 25, 2025, 6:00 PM EDT - 1 year ago

Rani Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results

Rani Therapeutics Holdings Transcript: 7th Annual Evercore ISI HealthCONx Conference

Dec 4, 2024, 12:55 PM EST - 1 year ago

Rani Therapeutics Holdings Transcript: 7th Annual Evercore ISI HealthCONx Conference

Rani Therapeutics Holdings Transcript: Stifel 2024 Healthcare Conference

Nov 18, 2024, 4:10 PM EST - 1 year ago

Rani Therapeutics Holdings Transcript: Stifel 2024 Healthcare Conference

Rani Therapeutics Holdings Transcript: UBS Global Healthcare Conference 2024

Nov 14, 2024, 1:15 PM EST - 1 year ago

Rani Therapeutics Holdings Transcript: UBS Global Healthcare Conference 2024

Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering and Cancellation of Certain Existing Warrants

Oct 15, 2024, 8:30 AM EDT - 1 year ago

Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering and Cancellation of Certain Existing Warrants

Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit

Oct 8, 2024, 4:05 PM EDT - 1 year ago

Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit

Rani Therapeutics Holdings Transcript: 2024 Cantor Fitzgerald Global Healthcare Conference

Sep 18, 2024, 11:30 AM EDT - 1 year ago

Rani Therapeutics Holdings Transcript: 2024 Cantor Fitzgerald Global Healthcare Conference

Rani Therapeutics to Participate in September Investor Conferences

Sep 3, 2024, 4:05 PM EDT - 1 year ago

Rani Therapeutics to Participate in September Investor Conferences

Rani Therapeutics Holdings Transcript: Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024

Aug 13, 2024, 3:30 PM EDT - 1 year ago

Rani Therapeutics Holdings Transcript: Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024

Rani Therapeutics Reports Second Quarter 2024 Financial Results; Provides Corporate Update

Aug 6, 2024, 4:05 PM EDT - 1 year ago

Rani Therapeutics Reports Second Quarter 2024 Financial Results; Provides Corporate Update

Rani Therapeutics to Participate in August Investor Conferences

Jul 29, 2024, 4:05 PM EDT - 1 year ago

Rani Therapeutics to Participate in August Investor Conferences

Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering

Jul 22, 2024, 8:30 AM EDT - 1 year ago

Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering

Rani Therapeutics Holdings Transcript: Investor Update

Jun 24, 2024, 8:00 AM EDT - 2 years ago

Rani Therapeutics Holdings Transcript: Investor Update

Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment

Jun 24, 2024, 7:00 AM EDT - 2 years ago

Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment

Rani Therapeutics Holdings Transcript: H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ

May 20, 2024, 2:30 PM EDT - 2 years ago

Rani Therapeutics Holdings Transcript: H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ

Rani Therapeutics to Participate in May Investor Conferences

May 14, 2024, 8:00 AM EDT - 2 years ago

Rani Therapeutics to Participate in May Investor Conferences

Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024

May 9, 2024, 8:00 AM EDT - 2 years ago

Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024

Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update

May 6, 2024, 4:05 PM EDT - 2 years ago

Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update

Rani Therapeutics Holdings Earnings Call Transcript: Q4 2023

Mar 20, 2024, 4:30 PM EDT - 2 years ago

Rani Therapeutics Holdings Earnings Call Transcript: Q4 2023

Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update

Mar 20, 2024, 4:05 PM EDT - 2 years ago

Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update

Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results

Mar 15, 2024, 4:05 PM EDT - 2 years ago

Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results

Rani Therapeutics Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin Triagonist

Dec 14, 2023, 8:00 AM EST - 2 years ago

Rani Therapeutics Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin Triagonist

Rani Therapeutics Reports Third Quarter 2023 Financial Results; Provides Corporate Update

Nov 8, 2023, 4:05 PM EST - 2 years ago

Rani Therapeutics Reports Third Quarter 2023 Financial Results; Provides Corporate Update

Rani Therapeutics Announces Successful Oral Delivery of Monoclonal Antibody via High-Capacity Pill in Preclinical Study

Oct 19, 2023, 4:05 PM EDT - 2 years ago

Rani Therapeutics Announces Successful Oral Delivery of Monoclonal Antibody via High-Capacity Pill in Preclinical Study

Rani Therapeutics to Present Abstract on RT-102 at the 2023 Annual Meeting of the American Society for Bone and Mineral Research

Oct 12, 2023, 4:05 PM EDT - 2 years ago

Rani Therapeutics to Present Abstract on RT-102 at the 2023 Annual Meeting of the American Society for Bone and Mineral Research

Rani Therapeutics Initiates Phase 1 Study of RT-111 (RaniPill® Containing Ustekinumab Biosimilar, CT-P43)

Sep 18, 2023, 8:00 AM EDT - 2 years ago

Rani Therapeutics Initiates Phase 1 Study of RT-111 (RaniPill® Containing Ustekinumab Biosimilar, CT-P43)

Rani Therapeutics Announces Successful Drug Delivery of High-Capacity Pill in Preclinical Studies

Sep 7, 2023, 4:05 PM EDT - 2 years ago

Rani Therapeutics Announces Successful Drug Delivery of High-Capacity Pill in Preclinical Studies

Rani Therapeutics Reports Second Quarter 2023 Financial Results; Provides Corporate Update

Aug 11, 2023, 4:05 PM EDT - 2 years ago

Rani Therapeutics Reports Second Quarter 2023 Financial Results; Provides Corporate Update

Rani Therapeutics' Presentation On Oral Delivery of PTH for Osteoporosis Named Presidential Poster Competition Winner at ENDO 2023 Annual Conference

Jun 21, 2023, 8:00 AM EDT - 3 years ago

Rani Therapeutics' Presentation On Oral Delivery of PTH for Osteoporosis Named Presidential Poster Competition Winner at ENDO 2023 Annual Conference

Rani Therapeutics Announces Acceptance of Late-Breaking Abstract of Oral Delivery of GLP-1 Agonist at the American Diabetes Association Annual Conference

Jun 8, 2023, 8:00 AM EDT - 3 years ago

Rani Therapeutics Announces Acceptance of Late-Breaking Abstract of Oral Delivery of GLP-1 Agonist at the American Diabetes Association Annual Conference

Rani Therapeutics and Celltrion Expand Partnership to Include Adalimumab Biosimilar for RT-105

Jun 5, 2023, 8:00 AM EDT - 3 years ago

Rani Therapeutics and Celltrion Expand Partnership to Include Adalimumab Biosimilar for RT-105

Rani Therapeutics to Present at the Jefferies Healthcare Conference

Jun 1, 2023, 8:00 AM EDT - 3 years ago

Rani Therapeutics to Present at the Jefferies Healthcare Conference

Rani Therapeutics Announces Acceptance of Three Abstracts for Presentation at ENDO 2023 Annual Conference

May 31, 2023, 8:00 AM EDT - 3 years ago

Rani Therapeutics Announces Acceptance of Three Abstracts for Presentation at ENDO 2023 Annual Conference

Rani Therapeutics Appoints Kate McKinley as Chief Business Officer

May 24, 2023, 8:00 AM EDT - 3 years ago

Rani Therapeutics Appoints Kate McKinley as Chief Business Officer

BBTAAPL
BBTAAPL May. 13 at 12:28 PM
$RANI what time earnings?
0 · Reply
wavw
wavw May. 13 at 2:15 AM
$RANI the ask at 1.12 is 84800. Why so high. Somebody betting either to short or parabolic move….last time similar move happened before it fell. Hope it goes up….
2 · Reply
BBTAAPL
BBTAAPL May. 12 at 11:44 PM
$WOK $RANI is another runner
0 · Reply
Fishbonee
Fishbonee May. 12 at 8:37 PM
$RANI
0 · Reply
BBTAAPL
BBTAAPL May. 12 at 12:57 PM
$RANI let’s roll this week! Back to the promise land
0 · Reply
randres
randres May. 12 at 12:40 PM
$RANI i think this week is the week🚀
0 · Reply
BBTAAPL
BBTAAPL May. 12 at 12:29 PM
$RANI what are the predictions for what happens next?
0 · Reply
wavw
wavw May. 12 at 12:26 PM
$RANI As of April 30, 2026, Rani Therapeutics (RANI) has a short interest of approximately 8.95 million shares, During this time period the stock fell below 1. Short sellers cover at very low price to maximize profits.
1 · Reply
Fishbonee
Fishbonee May. 11 at 8:31 PM
$RANI 📈 LFG
0 · Reply
BBTAAPL
BBTAAPL May. 11 at 7:48 PM
$RANI someone was buying today & knows something. About to get an AI pump
1 · Reply
wavw
wavw May. 11 at 2:27 PM
$RANI long way to go for my target
0 · Reply
BBTAAPL
BBTAAPL May. 11 at 2:25 PM
$RANI time to pump this up to $10!
2 · Reply
MK10
MK10 May. 11 at 2:07 PM
$RANI It's about time for this one to take a nice run:)
0 · Reply
AndyHazy
AndyHazy May. 11 at 1:57 PM
$RANI Hopefully we can say 👋 to the reverse split numpties
0 · Reply
Hi1254
Hi1254 May. 11 at 1:53 PM
$RANI nice move $CLSK 💚
0 · Reply
Bakhm
Bakhm May. 11 at 1:40 PM
$RANI Nice job
0 · Reply
Hakapeszi
Hakapeszi May. 11 at 11:42 AM
$RANI Interesting pre-market volume
1 · Reply
Bakhm
Bakhm May. 11 at 9:59 AM
$RANI Are they going to do something about this price, or are we really heading all the way to a reverse split
0 · Reply
YouGotaDeePlusTrades
YouGotaDeePlusTrades May. 11 at 6:52 AM
$RANI this is another one on my radar!
0 · Reply
APRadek
APRadek May. 9 at 8:58 AM
$RANI 3x 13F Vanguard 1x 13G Vanguard. That has to mean something
1 · Reply
Hi1254
Hi1254 May. 8 at 9:25 AM
$RANI $CLSKW $RR $SLNH
0 · Reply
Hi1254
Hi1254 May. 8 at 9:24 AM
$RANI
0 · Reply